ATS Medical

From WikiCover

Jump to: navigation, search

ATS Medical provides innovative products and services focused on cardiac surgery. The company, global in scope, has been headquartered in Minneapolis, Minnesota. More than 135,000 ATS Open Pivot Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3F brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus annuloplasty products for heart valve repair, SurgiFrost and FrostByte products for surgical cryoablation of cardiac arrhythmias, RTI-Cardiovascular for allograft tissue services, and the development of PARSUS blood filtration technology.



On June 28, 2007, ATS Medical announced the completion of its acquisition of the surgical cryoablation business of CryoCath Technologies. The assets being acquired include the SurgiFrost, FrostByte, and SurgiFrost XL family of products for which ATS Medical has been CryoCath's exclusive agent in the United States and distributor in certain international markets since November 2004.


Website: http://www.atsmedical.com/